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Immunization with vaccinia virus (VACV), the virus
comprising the smallpox vaccine, induces memory
CD8+ T cells that protect from subsequent infections
with smallpox in humans or the related ectromelia vi-
rus (ECTV) in mice. Memory CD8+ T cells largely
mediate these effects by expanding into secondary
effectors that secrete the antiviral cytokine inter-
feron-g (IFN-g) and induce cytolysis via releasing
factors such as perforin, which permeabilizes target
cells. We show that protection from ECTV infection
after VACV immunization depends on the initial mem-
ory cell frequency and ability of expanded secondary
effectors to kill infected targets in a perforin-depen-
dent manner. Although IFN-g is essential for antiviral
protection, it can be produced by either secondary
effectors or concomitant primary effector CD8+
T cells recruited to the response. Thus, during lethal
virus challenge, memory CD8+ T cells are required for
cytolytic killing of infected cells, but primary effectors
can play important roles by producing IFN-g.
INTRODUCTION
The severity of a viral infection, from asymptomatic to lethal, de-
pends on the balance between the swiftness and strength of the
innate and adaptive immune responses and the speed of virus
replication and spread in the permissive host. Vaccination ex-
pands the pool of antiviral lymphocytes and/or generates circu-
lating antibodies altering this balance in favor of the host. This
paradigm becomes vivid after footpad infection of different
mouse strains with the Orthopoxvirus (OPV) ectromelia virus
(ECTV). ECTV is a natural mouse pathogen that causes a disease
known as mousepox. It is genetically and antigenically very
similar to the virus of human smallpox and also to the virus in
the smallpox vaccine, vaccinia virus (VACV) (Fenner et al.,
1988). After footpad infection of all laboratory mouse strains,
ECTV spreads lymphohematogenously (LHY) to seed the546 Cell Host & Microbe 13, 546–557, May 15, 2013 ª2013 Elsevier Ivisceral organs, mainly the liver and spleen. However, the
outcome of the infection varies depending on the mouse strain.
C57BL/6 (B6) mice mount an effective innate natural killer cell
(NKC) response in the draining lymph node (D-LN) at 2 days
postinfection (dpi) followed by an adaptive CD8+ T cell response
that peaks in the D-LNs at 5 dpi and in the liver and spleen at 7
dpi (Fang et al., 2008, 2011; Fang and Sigal, 2005, 2006; Parker
et al., 2007). As a consequence, B6 mice suffer a relatively mild
infection without major clinical symptoms of disease. On the
other hand, mice of the strains BALB/c, A/J, DBA/2J, and B6
congenic B6.D2-(D6Mit149-D6Mit15)/LusJ (B6.D2-D6) (Davis
et al., 2005; Fang et al., 2011) generally succumb at 7–10 dpi,
most likely due to the high virus titers and consequential massive
necrosis of the liver (Wallace et al., 1985). In the case of the DBA/
2J strain, a susceptibility gene has been mapped to the distal re-
gion of chromosome 6. This region is known as the NK complex
(Delano and Brownstein, 1995) because it houses many NKC re-
ceptor genes, including Klrd1, which encodes CD94 and is not
expressed in DBA2/Jmice (Vance et al., 2002). Notably,Klrd1/
B6 mice and B6.D2-D6 mice, which are congenic B6 mice with
the NKC complex from DBA2/J mice, are susceptible to mouse-
pox and both can be rescued by transgenic expression of CD94
(Fang et al., 2011).
As with humans and smallpox, susceptible mice can be pro-
tected from mousepox by immunization with VACV (Fenner,
1994). Thus, ECTV can be used as an invaluable experimental
model to understand how the smallpox vaccine protects. In
addition to its importance as a smallpox model, ECTV is a text-
bookmodel for themany human and animal viruses that become
systemic and cause disease by disseminating LHY (Flint et al.,
2009). Hence, ECTV is uniquely suited to study the mechanisms
of acquired protection against the many viruses that spread us-
ing this route.
CD8+ T cells play a major role in antiviral immunity. Antiviral
CD8+ T cells become effectors and proliferate when their T cell
receptor specifically recognizes viral peptide determinants
bound to major histocompatibility class I molecules (MHC I) at
the surface of antigen presenting cells. Effector CD8+ T cells
contribute to reduce the severity of disease by killing infected
cells and by producing antiviral cytokines (Harty et al., 2000).
The major antiviral cytokine produced by effector CD8+ T cells
is interferon-g (IFN-g) and the main cytolytic mechanism ofnc.
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proapoptotic enzymes, prominently granzyme B (GzB), into the
cytosol of the target cell through pores formed by perforin (Prf)
(Trapani and Smyth, 2002). However, IFN-g production and
granule exocytosis mediated-killing are hallmarks but not the
exclusive domain of CD8+ T cells. NKCs, which recognize tar-
gets through germline encoded receptors, use these exact
same mechanisms to control viruses during the early stages of
infection (Cerwenka and Lanier, 2001). Moreover, IFN-g produc-
tion and granule exocytosis-mediated killing are also functions of
NK T cells and CD4+ T cells (Billiau and Matthys, 2009; Fang
et al., 2012; Marshall and Swain, 2011; Tupin et al., 2007).
If a virus is eliminated,most of the effector CD8+ T cells die, but
an expanded pool of virus-specific CD8+ T cells remains. These
memory CD8+ T cells coexist with a naive pool of antiviral CD8+
T cells that may have been present during the primary infection
but did not encounter antigen or may be newly produced (Martin
et al., 2011). When a subsequent infection with a pathogen that
carries the appropriate viral peptide determinants occurs, the
memory CD8+ T cells rapidly become secondary effectors and
expand. Similar to the primary effectors, these secondary effec-
tors can kill infected cells and produce IFN-g, diminishing the
seriousness of the infection (Welsh et al., 2004). Of note, by
reducing virus loads, killing antigen-presenting cells, and/or ad-
vantageously competing for access to them, memory CD8+
T cells can also dampen the response of the coexisting antiviral
naive cells (Guarda et al., 2007; Kedl et al., 2000). Yet, concom-
itant primary and secondary responses can occur, as demon-
strated in other infection models (Badovinac et al., 2003; Martin
et al., 2012; Martin et al., 2011; Turner et al., 2001). However,
whether these concomitant primary responses can help combat
the infection is unknown.
After primary infection, mousepox-susceptible mice, such
as Klrd1/ B6 mice and B6.D2-D6 mice, fail to mount CD8+
T cell responses (Fang et al., 2006; Fang et al., 2011). However,
they mount strong CD8+ T cell responses to VACV. Due to
their genetic similarity, most CD8+ T cell determinants from
VACV and ECTV are identical (Remakus et al., 2012; Tscharke
et al., 2005, 2006). As a consequence, memory CD8+ T cells
from VACV-immune mice protect susceptible BALB/c mice
from mousepox (Xu et al., 2007). Hence, the pairing of VACV
immunization and challenge with ECTV serves as a unique
model to study how memory CD8+ T cells protect from a lethal
disease that spreads LHY within the context of a highly
successful human vaccine. Using this model, we have previously
shown that a major mechanism whereby memory CD8+ T cells
protect from mousepox is by curbing lymphohematogenous
(LH) spread (Xu et al., 2007). They do this by rapidly becoming
secondary effectors and proliferating in the D-LN. However,
given that other cells have similar functions, it is still unknown
whether for this or any other infection protection from disease
requires the secondary effectors to kill infected cells and also
to produce IFN-g. Moreover, it is also unknown whether
concomitant primary and secondary responses can occur
during infections with highly virulent viruses that normally curtail
the primary CD8+ T cell response of the naive host. If so, it is
possible that the concomitant primary response could play a
role in protection, particularly if the secondary effectors are
suboptimal.Cell HHere we demonstrate that in the absence of other sources, the
IFN-g produced by secondary effectors is necessary and suffi-
cient for protection from mousepox. However, when other sour-
ces of IFN-g are available, the secondary effectors need to be
capable of granule exocytosis-mediated killing but not IFN-g
production because this function can be complemented by a
concomitant primary response. Our findings help understand
the mechanisms whereby memory CD8+ T cells protect from
viral diseases and unveil a hitherto unknown role for concomitant
primary CD8+ T cell responses during the course of a secondary
CD8+ T cell response.
RESULTS
In the Absence of Other Sources, IFN-g Produced by
Memory CD8+ T Cells Is Necessary and Sufficient for
Protection from Mousepox
To investigate the need for IFN-g during protection by memory
CD8+ T cells, we took advantage of the fact that IFN-g/ mice
(B6.129S7-Ifngtm1Ts/J, IFN-g/) survive VACV infection and
maintain a large memory CD8+ T cell pool that is highly cross-
reactive with ECTV (Remakus et al., 2012; Remakus and Sigal,
2011). We transferred 5 3 106 purified CD8+ T cells obtained
from naive wild-type (WT) B6 (N-WT) mice or VACV-immune
WT B6 (M-WT) or IFN-g/ B6 (M-IFN-g/) mice into naive
IFN-g/mice. One day after transfer, the mice were challenged
with ECTV. All mice that were recipients of N-WT cells suc-
cumbed, while all those that received M-WT survived the
infection (Figure 1A) with minimal weight loss (Figure 1B). On
the other hand, most M-IFN-g/ recipients succumbed (Fig-
ure 1A), and the few that survived became very sick as indicated
by major weight loss (Figure 1B). Consistent with the survival
data, the virus loads in the livers and spleens of M-WT recipients
were several orders of magnitude lower than in those that
received M-IFN-g/ or N-WT CD8+ T cells (Figures 1C and
1D). Histological analysis at 7 dpi showed that the livers of
IFN-g/ mice that were recipients of N-WT or M-IFN-g/
CD8+ T cells were necrotic, were devoid of markedmononuclear
cell infiltrates localized in the lesions, had extensive hepatocellu-
lar necrosis, and had a large number of foci that stained with
rabbit antisera to the structural ECTV protein EVM-135. In
contrast, the livers of IFN-g/ mice that received M-WT CD8+
T cells had very few necrotic areas, low tissue damage, a high
number of infiltrating lymphocytes in lesions, and significantly
less EVM135+ foci than those that received N-WT or M-IFN-
g/ CD8+ T cells (Figure S1 available online). We also analyzed
the CD8+ T cell responses at 7 dpi in the livers and spleens of
IFN-g/ mice that were recipients of N-WT, M-WT and
M-IFN-g/ CD8+ T cells. Liver-infiltrating mononuclear cell
(LIMC) counts in the livers were comparable in all infected
IFN-g/ mice and significantly higher than in uninfected mice
(Figure 2A; representative flow cytometry plots in Figure S2).
Splenocyte counts (Figure 2G) were higher in M-WT and
M-IFN-g/ recipients than in uninfected mice (because some
N-WT recipients succumbed before the analysis, we were un-
able to statistically compare themwith the other groups for these
parameters). However, in both liver and spleen, the absolute
number of total CD8+ T cells (Figures 2B and 2H), total CD8+













































































Figure 1. M-WT but Not M-IFN-g–/– CD8+ T
Cells Efficiently Protect IFN-g–/– Mice from
Mousepox
(A) IFN-g/ mice received 5 3 106 N-WT, M-WT,
or M-IFN-g/CD8+ T cells and were infected with
ECTV. Survival was monitored. The experiment is
representative of three, where n = 5 for every group
except for M-IFN-g/, where n = 6.
(B) The mice in (A) were weighed daily.
(C) IFN-g/ mice that received 5 3 106 N-WT,
M-WT, or M-IFN-g/ CD8+ T cells were infected
with ECTV. Seven days postinfection, mice were
killed and virus titers were determined in liver. Data
correspond to five mice per group ± SEM and are
representative of two independent experiments.
(D) As in (C), but the virus titers were determined in
spleen.
See also Figure S1 for liver pathology.
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immunodominant determinant TSYKFESV+ as detected with Kb-
TSYKFESV dimers (Dimer X, BD) (Figure 2D and J) were signifi-
cantly higher in M-WT and M-IFN-g/ recipients than in N-WT
recipients (note that GzB expression does not require ex vivo re-
stimulation during acute ECTV infection and serves as a marker
of total antiviral effector CD8+ T cells [Fang and Sigal, 2005]).
Also, after ex vivo restimulation with TSYKFESV, there was
significantly more CD107a-positive LIMCs and splenic CD8+
T cells from M-WT and M-IFN-g/ recipients than from N-WT
recipients (Figures 2E and 2K), which is a marker of cytotoxic
CD8+ T cell degranulation (Betts et al., 2003). As expected,
only those cells from M-WT recipients produced IFN-g (Figures
2F and 2L). These experiments demonstrate that the presence
of IFN-g is essential during protection by memory CD8+ T cells
and that the memory CD8+ T cells can produce all the IFN-g
required for protection. These experiments also show that IFN-
g-deficient memory cells respond but do not protect in an IFN-
g-deficient environment.
IFN-g–/– but Not Prf–/– Memory CD8+ T Cells Protect
Susceptible IFN-g+ Mice from Lethal Mousepox
Given that M-IFN-g/ cells did not protect IFN-g/ mice but
were able to respond to ECTV, we next tested whether they
could protect mousepox-susceptible IFN-g-sufficient B6.D2-
D6mice. Because Prf is another major CD8+ T cell effector mole-
cule required for granule exocytosis-mediated killing, we also
tested whether memory CD8+ T cells obtained from Prf-deficient
(M-Prf/) mice could protect from lethal mousepox. Graded
numbers of N-WT, M-WT, M-IFN-g/, or M-Prf/ CD8+
T cells were adoptively transferred into B6.D2-D6 mice. The pro-
portion of Kb-TSYKFESV-specific cells in the transferred popula-
tions was determined by flow cytometry (Figure 3A) and was
used to calculate the approximate number of Kb-TSYKFESV-
specific cells transferred. Upon ECTV challenge, all B6.D2-D6
mice that received N-WT or M-Prf/ cells died, although the
death of the M-Prf/ recipients was slightly but significantly de-
layed (Figures 3B and 3C). All the mice that received 60,000
or more Kb-TSYKFESV-specific M-WT or M-IFN-g/ CD8+
T cells were significantly protected from death and did not548 Cell Host & Microbe 13, 546–557, May 15, 2013 ª2013 Elsevier Ishow symptoms of disease except for relatively minor weight
loss. Protection by the memory cells was dose dependent
because all of the mice succumbed when adoptively transferred
with only 25,000 Kb-TSYKFESV-specific M-WT CD8+ T cells
(data not shown). Virus loads in liver (Figure 3D) and spleen (Fig-
ure 3E) at 7 dpi were significantly lower in M-WT andM-IFN-g/
than inM-Prf/ andN-WTB6.D2-D6 recipients. While therewas
a tendency for higher virus loads in mice recipient of M-IFN-g/
than in M-WT, it was not statistically significant. Compared to
those in N-WT recipients, the virus titers in the liver of M-Prf/
recipients were moderately but significantly decreased indi-
cating a low level of protection, which could explain their delayed
death. Thus, contrary to what occurs with IFN-g/mice, M-IFN-
g/ cells can protect susceptible B6.D2-D6 mice from lethal
mousepox. This suggests that the memory CD8+ T cells can out-
source the necessary IFN-g production to other cells to protect
from lethal mousepox. On the other hand, the expression of Prf
cannot be outsourced.
Endogenous Prf but Not IFN-g in Memory CD8+ T Cells Is
Required for the Early Control of ECTV LH Spread
We have previously shown in BALB/c mice that that memory
CD8+ T cells curb LH spread to the liver and spleen. Similarly,
at 4 dpi, the virus loads in the liver (Figure 4A) and spleen (Fig-
ure 4B) of M-WT and M-IFN-g/ B6.D2-D6 recipients were
significantly lower than in N-WT and M-Prf/ B6.D2-D6 recipi-
ents. While there was some significant protection of the spleen
in M-Prf/ recipients, it was much less pronounced than in
M-WT or M-IFN-g/ recipients. To identify the mechanism of
the early protection of the liver and spleen, we transferred
CFSE-labeled N-WT, M-WT, M-IFN-g/, or M-Prf/ CD8+
T cells into double-congenic B6.D2-D6 mice carrying the
Thy1.1 allele (B6.D2-D6-Thy1.1). Consistent with our previous
experiments in BALB/c mice, there were no significant donor-
or host-derived CD8+ T responses in the liver or spleen at 4 dpi
(data not shown), indicating that the protection of the liver and
spleen at 4 dpi was not due to in situ responses. However, at 4
dpi, the D-LNs of M-WT- and M-IFN-g/- but not M-Prf/-
recipient mice were enlarged, with more than twice the total
number of cells than uninfected mice or N-WT recipientsnc.
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Figure 2. M-WT and M-IFN-g–/– CD8+ T Cells Respond Strongly in the Liver and Spleen of IFN-g–/– Mice
IFN-g/mice received 53 106 N-WT, M-WT, or M-IFN-g/ CD8+ T cells. One day later, the mice were infected with ECTV, and at 7 dpi the mononuclear cells
infiltrating the livers (A–F) and splenocytes (G–L) were incubated for 5 hr with TSYKFESV or without peptide, and the indicated parameters were determined. Data
correspond to an experiment with five mice per group ± SEM, with exception of N-WT, which had two mice per group because three mice died at 7 dpi. Data are
representative of two experiments. Data are represented as mean ± SEM. See also Figure S2 for representative flow cytometry plots.
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Antiviral Memory CD8+ T Cells Can Outsource IFN-g(Figure 4C). In addition, compared to uninfected mice, the total
numbers of CD8+ T cells in the D-LN of M-WT and M-IFN-g/
were significantly increased but not different in Prf/ recipients.
On the other hand, the relative (data not shown) and absolute
numbers of CD8+ T cells were significantly decreased in N-WT
recipients (Figure 4D) The number of donor (Thy1.2+) CD8+
T cells in M-WT and M-IFN-g/ recipients was also significantlyCell Hhigher than in N-WT or M-Prf/ recipients (Figures 4E and 4F).
Most M-WT and M-IFN-g/ but not M-Prf/ or N-WT cells in
the D-LN were effectors because they had divided extensively
as indicated byCFSE dilution (Figures 4E and 4G) and expressed
GzB (Figure 4H). Thus, the early protection of the liver and spleen
in M-WT- and M-IFN-g/-recipient mice was due to a rapid
































































































Figure 3. Memory CD8+ T Cells Deficient in IFN-g but Not in Prf Protect Susceptible Mice from Lethal Mousepox
CD8+ cells were magnetically purified from pooled LNs and spleens from donor naive or VACV-immune B6, IFN-g/, or Prf/mice. CD8+-purified CD8+ T cells
(106, 2.5 3 106 or 53 106) from each type of donor cell were transferred intravenously into groups of five B6.D2-D6 mice. One day later, the mice were infected
with ECTV and survival was monitored.
(A) The frequency of CD8+ T cells specific for the immunodominant determinant TSYKFESV was determined by staining with Kb-TSYKFESV dimers.
(B) Kaplan-Meier survival curve for mice transferred with 65,000 Kb-TSYKFESV+ cells as determined from the results in (A).
(C) Kaplan-Meier survival curve for mice transferred with130,000 Kb-TSYKFESV+ cells as determined from the results in (A). All mice transferred with 106 M-WT
or M-Prf/ (25,000 Kb-TSYKFESV+ cells) succumbed to the infection, all the mice transferred with 5 3 106 M-IFN-g/ (270,000 Kb-TSYKFESV+ cells)
survived and are not displayed graphically.
(D and E) Virus titers at 7 dpi in livers (D) and spleens (E) from B6.D2-D6-Thy1.1+ mice that received 53 106 N-WT CD8+ T cells or enough M-WT, M-IFN-g/, or
M-Prf/CD8+ T cells to contain75,000 Kb-TSYKFESV+ cells. Data are represented as a mean ± SEM and are representative of two independent experiments.
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(probably due to their failure to rapidly kill infected cells) curtailed
their own response in the D-LN (likely because they became in-
fected and died).
We have previously shown that B6.D2-D6 mice infected with
WT ECTV do not mount primary CD8+ T cell responses to
ECTV and succumb to mousepox (Fang et al., 2011). However,
treatment of B6.D2-D6 mice with the antiviral drug Cidofovir at
2 dpi prevented mousepox (data not shown) and enabled a
strong primary CD8+ T cell response (Figure S3A). This demon-
strates that the failure of B6.D2-D6 mice to generate potent pri-
mary CD8+ T cell responses during ECTV infection is not due to
intrinsic defects of the CD8+ T cells or accessory cells but, most
likely, to excessive viral replication. Thus, we studied whether,
similar to Cidofovir, protective memory CD8+ T cells enable pri-
mary CD8+ T cell responses to ECTV by looking for a primary
anti-ECTV CD8+ T cell response (Thy1.2–) in the D-LN of the
B6.D2-D6-Thy1.1-recipient mice. Interestingly, the absolute
number of total Thy1.2– CD8+ T cells (Figure 4I) and of Thy1.2–
GzB+ CD8+ T cells (Figure 4J) was significantly higher in M-WT
and M-IFN-g/ recipients than in N-WT recipients. Thus, pro-
tective M-WT and M-IFN-g/ CD8+ T cells enabled a primary
CD8+ T cell response in the D-LN. Given the small size of the
D-LNs, a more-detailed analysis of the primary response was550 Cell Host & Microbe 13, 546–557, May 15, 2013 ª2013 Elsevier Inot possible in these mice. In a related experiment, naive
(N-EGFP) or VACV-immune (M-EGFP) CD8+ T cells from
C57BL/6-Tg(CAG-EGFP)1Osb/J (B6-EGFP) mice that express
enhanced green fluorescence protein (EGFP) ubiquitously were
transferred into B6.D2-D6 mice that were infected or not with
ECTV expressing the red fluorescence protein mCherry (ECTV-
mCherry). The D-LNs were collected at 5 dpi and analyzed by
confocal microscopy. The results suggested that M-EGFP
decreased the spread of the infection from the paracortical areas
into the medulla of the D-LN, providing some insights into how
memory cells could prevent virus spread (Figure S3B).
Endogenous Prf but Not IFN-g in Memory CD8+ T Cells Is
Required for the Late Control of ECTV in the Liver and
Spleen
Given that naive B6.D2-D6 mice succumb to ECTV starting at
7 dpi, we also analyzed the response and effects of the different
memory CD8+ T cells at this time point in the liver and spleen.
M-WT, M-IFN-g/, and M-Prf/ recipients had significantly
higher numbers of LIMCs as compared to N-WT recipients and
uninfected controls (Figure 5A; representative flow cytometry
plots for Figure 5 can be found in Figures S4A and S4B). More
LIMCs were CD8+ T cells in M-WT andM-IFN-g/ as compared
to M-Prf/ recipients in relative and absolute numbers (Figuresnc.
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showed that Kb-TSYKFESV-specific (Figure 5D) and GzB+
LIMCs (Figure 5E) were present in M-WT, M-IFN-g/, and
M-Prf/ recipients but not in N-WT recipients. However, their
absolute numbers were significantly higher in M-WT and
M-IFN-g/ than in M-Prf/ recipients. After ex vivo restimula-
tion with TSYKFESV, many LIMCs expressed IFN-g in M-WT
and M-Prf/ recipients but not in M-IFN-g/ recipients (Fig-
ure 5F). Analysis of the host-derived (Thy1.2–) primary response
showed significantly higher numbers of Kb-TSYKFESV-specific
(Figure 5G) and GzB+ (Figure 5H) LIMCs in M-WT and M-IFN-
g/ than in M-Prf/. After ex vivo restimulation with
TSYKFESV, a significant number of host-derived CD8+ T LIMCs
expressed IFN-g in M-WT, M-Prf/ and, importantly, also in
M-IFN-g/ recipients (Figure 5I). Spleens were lymphopenic in
most N-WT and M-Prf/ recipients, while those in M-WT and
M-IFN-g/ recipients had increased cellularity (Figure 5J). The
frequency of splenic CD8+ T cells was unchanged in M-WT
andM-IFN-g/ recipients, decreased or unchanged in N-WT re-
cipients, and significantly increased in M-Prf/ recipients, sug-
gesting that activated cells were not killed by the virus but resting
cells were (Figure 5K). As compared to uninfected mice, the ab-
solute numbers of CD8+ T cells in the spleens of N-WT recipients
were significantly decreased, but they were not significantly
affected in recipients of memory CD8+ T cells (Figure 5L). Anal-
ysis of Thy1.2+ donor-derived CD8+ T cells showed significantly
higher numbers of Kb-TSYKFESV-specific (Figure 5M) and GzB+
(Figure 5N) cells in M-WT, M-IFN-g/, and M-Prf/ as
compared to N-WT recipients. After ex vivo restimulation with
TSYKFESV, a significant number of donor-derived CD8+ T cells
expressed IFN-g in M-WT and M-Prf/ but not in M-IFN-g/
recipients (Figure 5O). While smaller compared to the donor-
derived, significant numbers of host-derived (Thy1.2–) Kb-
TSYKFESV-specific (Figure 5P) and GzB+ (Figure 5Q) cells were
present in M-WT, M-IFN-g/, and M-Prf/ but not in N-WT re-
cipients. After ex vivo restimulation with TSYKFESV, a small but
significant number of host-derived CD8+ T cells expressed
IFN-g in M-WT, M-Prf/, and also M-IFN-g/ but not N-WT
recipients (Figure 5R). Thus, M-IFN-g/ cells were at least as
effective as M-WT cells at mounting a response in the liver and
spleen, at enabling a primary response that produced IFN-g,
and at protecting from splenocyte loss. On the other hand,
M-Prf/ CD8+ T cells were less able to respond or enable a pri-
mary response in the liver, and while they responded strongly in
the spleen, they were unable to protect from splenocyte loss.
It was of interest to determine whether concomitant primary
responses to ECTV can also occur in resistant B6 mice that nor-
mally mount a strong primary response to ECTV and whether
very high numbers of memory CD8+ T cells could inhibit the
concomitant primary response. For this purpose, B6 mice were
transferred with 5 3 106 (M-WTLOW) or 30 3 106 (M-WTHIGH)
CD8+ T cells from VACV-immune mice, and their CD8+ T cell re-
sponses were determined in the spleen at 7 dpi (Figure S4C). We
found that although theywere reduced in comparison to untrans-
ferred controls, concomitant primary responses occurred in the
presence of both M-WTHIGH andM-WTLOW cells. While the pres-
ence of concomitant primary and secondary responses have
been described for other pathogens infected through the intrave-
nous or respiratory routes (Badovinac et al., 2003; Martin et al.,Cell H2011, 2012; Turner et al., 2001), whether they are unique to
ECTV or also occur for other pathogens when introduced via
the footpad has not been explored. We found concomitant pri-
mary and secondary responses not only to VACV (which is
nonpathogenic but antigenically almost identical to ECTV) but
also to lymphocytic choriomeningitis virus (LCMV) Armstrong,
a nonlytic RNA virus that naturally infects mice but does not
cause disease after footpad inoculation (Figures S4D and S4E).
In the presence of the memory cells, primary responses to
VACV were partially inhibited, but those to LCMV were un-
changed. Thus, after footpad infection, concomitant primary
and secondary responses occur not only to ECTV in mousepox
susceptible mice but also to ECTV in mousepox-resistant
mice, to nonpathogenic VACV, and to noncytolytic LCMV.
N-WT T Cells Can Complement M-IFN-g–/– CD8+ T Cells
to Protect IFN-g–/– Mice from Mousepox
Not only CD8+ T but also CD4+ T and NKCs can produce IFN-g.
We therefore investigated whether any of these populations from
naive B6 mice could complement the ability of the IFN-g/
memory CD8+ T cells to protect frommousepox. In a preliminary
experiment, we found that most IFN-g/ mice that received
M-IFN-g/ CD8+ T cells combined with a large number (4 3
107) of total leukocytes pooled from spleens, LNs, and livers of
naive mice survived (N-WT leukocytes). Reduction of the dose
of N-WT leukocytes resulted in decreased survival with all the
mice receiving M-IFN-g/ CD8+ T cells combined with only
107 N-WT leukocytes succumbing to mousepox. All IFN-g/
mice that had been transferred with 4 3 107 N-WT leukocytes
alone also succumbed to mousepox, indicating that this large
number of IFN-g-sufficient naive cells in the absence of memory
CD8+ T cells was not protective. As before, M-IFN-g/ cells
alone did not protect the IFN-g/mice (Figure S5). Thus, a suf-
ficient number of N-WT leukocytes can complement M-IFN-g/
CD8+ T cells to protect frommousepox. To identify which leuko-
cyte populations were capable of complementing the M-IFN-
g/ CD8+ T cells, we performed adoptive transfer experiments
where the donors of N-WT leukocytes had been depleted of
NKCs, CD4+ T cells, CD8+ T cells, or CD4+ and CD8+ T cells
1 day before harvest and transfer (Figure 6). All mice that
receivedM-IFN-g/CD8+ T cells combinedwith total N-WT leu-
kocytes or M-IFN-g/CD8+ T cells combined with N-WT leuko-
cytes from NKC-depleted mice survived the infection without
major weight loss. This indicated that production of IFN-g by
NKCs is not essential to complement protection by M-IFN-g/
CD8+ T cells. On the other hand, most mice transferred with
M-IFN-g/ CD8+ T cells together with N-WT leukocytes from
mice depleted of CD4+ and CD8+ T cells succumbed to mouse-
pox, indicating that N-WT T cells can complement M-IFN-g/
CD8+ T cell protection from mousepox. Most mice that received
M-IFN-g/ CD8+ T cells together with N-WT leukocytes from
either CD4+-T-cell- or CD8+-T-cell-depleted mice survived
ECTV challenge, indicating that either CD4+ or CD8+ T cells
can complement the protective capacity of M-IFN-g/ CD8+
T cells. Control mice that received either M-IFN-g/ CD8+
T cells or total N-WT leukocytes alone succumbed tomousepox.
Thus, WT CD4+ or CD8+ T cells recruited from the naive pool can
complement IFN-g-deficient memory CD8+ T cells to protect
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Based on correlation, Panchanathan et al. have argued that only
antibodies can protect from mousepox (Panchanathan et al.,
2010). Contrary to this view, we have previously shown that
memory CD8+ T cells are effective at protecting susceptible
mice from lethal mousepox and visible symptoms of disease
(Remakus et al., 2012; Xu et al., 2007). Furthermore, we have
shown that circulating antibodies and memory CD8+ T cells fulfill
a similar role; they subdue the spread of the virus, tipping the bal-
ance in favor of the host and allowing for the development of a full
immune response (Xu et al., 2007). Here we investigated whether
intrinsic or extrinsic IFN-g and granule exocytic killing are
required during memory CD8+ T cells protection from
mousepox.
Naive IFN-g/ and IFN-g-receptor-deficient (IFN-gR/) mice
succumb to footpad ECTV infection within 7–9 dpi (Chaudhri
et al., 2004; Karupiah et al., 1993). However, IFN-gR/ mice
resist a secondary challenge with virulent ECTV if previously
immunized with an attenuated ECTV strain, indicating that
IFN-g is not essential for resistance to secondary ECTV infection.
However, this protection was mediated by antibodies (Pancha-
nathan et al., 2005). Here we have shown that IFN-g is not essen-
tial for strong memory CD8+ T cell responses to ECTV, because
M-IFN-g/ CD8+ T cells responded swiftly in IFN-g/ mice.
Indeed, they responded stronger than M-WT CD8+ T cells
most likely because in these experiments we transferred equal
number of total CD8+ T cells that have higher frequency of mem-
ory cells in VACV-immunized IFN-g/ than WT B6 mice (Rema-
kus and Sigal, 2011) or, less likely, because a higher rate of
expansion of the M-IFN-g/ cells. Still, despite their strong re-
sponses, M-IFN-g/ CD8+ T cells did not protect M-IFN-g/
mice from mousepox. This indicates that, distinct from anti-
body-mediated protection, the presence of IFN-g is crucial dur-
ing memory CD8+ T cell protection. On the other hand, M-WT
CD8+ T cells fully protected IFN-g/ mice from mousepox,
demonstrating that the responding memory cells can be the
sole source of the necessary IFN-g.
Despite the need for IFN-g during protection by memory CD8+
T cells, we also found that WT and IFN-g/ memory CD8+
T cells controlled early ECTV LH spread and protected suscep-
tible B6.D2-D6mice frommousepox. This was the direct result of
their ability to kill infected cells in the D-LN because Prf/mem-
ory CD8+ T cells did not prevent early LH spread or protect from
mousepox. Consequently, memory CD8+ T cells have to be
capable of Prf-dependent killing but not IFN-g production to pre-
vent mousepox in susceptible B6.D2-D6 mice.
We also found that protection by IFN-g-sufficient and -defi-
cient memory CD8+ T cells was highly dependent on their initial
frequency. Hence, while 25,000 M-WT CD8+ T cells did notFigure 4. Endogenous Prf but Not IFN-g in Memory CD8+ T Cells Is Re
(A and B) Virus titers at 7 dpi in livers (A) and spleens (B) from B6.D2-D6mice that r
CD8+ T cells to contain 75,000 Kb-TSYKFESV+ cells. Data are representative o
(C–J) N-WT, M-WT, M-IFN-g/, or M-Prf/ CD8+ T cells were labeled with CFS
M-WT, M-IFN-g/, or M-Prf/CD8+ T cells that contained75,000 Kb-TSYKFE
were infected with ECTV, and at 4 dpi D-LN cells were counted and analyzed by fl
as a mean ± SEM and are representative of two similar experiments. Representa
See also Figure S3 for Cidofovir-treated mice and confocal microscopy.
Cell Hprotect any mouse from mousepox, 60,000 or more of these
cells was highly protective. Accordingly, the requirement for a
high frequency of memory CD8+ T cells may be due to the
need for direct contact between infected cells and the memory
CD8+ cells to exert killing. Hence, we suggest that it may be
necessary to revise how physiologically relevant CD8+ T cell
memory is currently measured.While polyfunctionality is a corre-
late of disease progression in elite HIV controllers, the absence
of polyfunctional memory T cells after vaccination (Betts et al.,
2006; Kannanganat et al., 2007; Precopio et al., 2007) may not
necessarily indicate suboptimal protection. Thus, instead of as-
sessing T cell functional superiority by the ability of T cells to
coproduce multiple cytokines, it may be important to focus on
memory CD8+ T cell frequency or their ability to protect from
disease.
Given that IFN-g is absolutely required during protection by
memory CD8+ T cells, it was important to identify the source of
IFN-g during protection by M-IFN-g/ cells. After virulent
ECTV infection, naive B6 mice mount very strong primary
CD8+ T cell responses, while naive B6.D2-D6 mice do not
(Fang et al., 2011). Our experiments show that in the presence
of memory CD8+ T cells, the primary CD8+ T cell responses of
B6.D2-D6 mice to virulent ECTV were enabled in the D-LN, liver,
and spleen. Moreover, we showed that protection of IFN-g/
mice by M-IFN-g/ could be achieved if adequate numbers of
IFN-g+ naive T cells were present. While some reports have
demonstrated that memory CD8+ T cells can outcompete naive
CD8+ T cells by limiting their access to or by killing antigen pre-
senting cells (Guarda et al., 2007; Kedl et al., 2000), our finding of
concomitant primary and secondary responses after footpad
infection is not unique to B6.D2-D6 mice or to ECTV infection,
but also occurs after infection of resistant B6-CD45.1 mice
with virulent ECTV even after transfer of very large numbers of
memory CD8+ T cells and after infection with nonvirulent VACV
and noncytolytic LCMV. Simultaneous primary and secondary
responses have also been shown for other pathogens (Badovi-
nac et al., 2003; Martin et al., 2011, 2012; Turner et al., 2001).
However, in most of these cases and in our experiments with
VACV, there was partial inhibition of the primary response prob-
ably because the pathogen is well controlled in the naive host.
On the other hand, the primary response to virulent ECTV was
enabled.
How do thememory CD8+ T cells enable the primary response
to virulent ECTV? Several lines of evidence suggest that the
inability of naive B6.D2-D6mice tomount primary CD8+ T cell re-
sponses to virulent ECTV is due to the excessive replication of
the virus and not to intrinsic deficiencies in the CD8+ T cells or
the antigen presenting cells: (1) Klrd1/ mice, which have the
exact same genetic deficiency as B6.D2-D6 mice, mount
perfectly normal CD8+ T cell responses to VACV, which sharesquired for the Early Control of ECTV LH Spread
eceived 53 106 N-WTCD8+ T cells, or enoughM-WT, M-IFN-g/, or M-Prf/
f three independent experiments.
E to identify divided donor cells. Five million N-WT CD8+ T cells or a number of
SV+ cells were transferred into B6.D2-D6-Thy1.1+ mice. One day later, the mice
ow cytometry. The indicated parameters were analyzed. Data are represented
tive flow cytometry plots are shown in (E).
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AB
Figure 6. N-WT T cells can complement M-
IFN-g–/– CD8+ T cells to protect IFN-g–/–
mice from mousepox.
IFN-g/ mice were transferred with 2.5 3 106
M-IFN-g/ CD8+ T cells and/or with 5 3 107 leu-
kocytes (pooled splenocytes, LN cells, and liver
mononuclear cells) from naive B6 mice that had
been depleted or not of CD4+, CD8+, CD4+, and
CD8+ T cells or NKCs as indicated. One day after
transfer, the mice were challenged with ECTV in
the footpad. Survival (A) and weight loss (B) are
shown. Data correspond to the mean of five mice
per group ± SEM and are representative of two
independent experiments. See also Figure S5.
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Antiviral Memory CD8+ T Cells Can Outsource IFN-gthe same determinants with ECTV but replicates poorly in mice
(Fang et al., 2011). (2) CD8+ T cells from B6.D2-D6 and Klrd1/
mice mount similar responses when adoptively transferred to B6
mice (Fang et al., 2011). (3) Inhibition of viral replication with the
antiviral drug Cidofovir at 2 dpi enabled the primary CD8+ T cell
response to virulent ECTV in B6.D2-D6 mice (Figure S3A).
Hence, the enablement of a concomitant naive response to viru-
lent ECTV by the memory CD8+ T cells resulted from their ability
to reduce virus replication. This reduction in virus replication was
mostly the consequence of cytolytic killing, because Prf/
M-CD8+ T cells did not reduce virus replication or efficiently
enable a primary response.
In summary, our experiments demonstrate that during protec-
tion by memory CD8+ T cell from a lethal OPV disease that
spreads LHY, IFN-g and cytolytic killing are both essential. How-
ever, while the production of IFN-g can be outsourced to
concomitant primary effectors, the ability of the responding
memory CD8+ T cells to kill infected cells cannot be replaced.
These data are important for our understanding of antiviral im-
munity and should be instrumental for designing and evaluating
antiviral vaccines.EXPERIMENTAL PROCEDURES
Viruses
Stocks were produced and titers determined as previously described (Fang
et al., 2011; Fang and Sigal, 2006, 2010; Xu et al., 2007).Figure 5. Endogenous Prf but Not IFN-g in Memory CD8+ T Cells Is Required for the Late Cont
B6.D2-D6-Thy1.1+ mice received 53 106 N-WT CD8+ T cells or enough M-WT, M-IFN-g/, or M-Prf/ CD8
One day later, the mice were infected with ECTV, and at 7 dpi liver-infiltrating mononuclear cells (A–I) an
TSYKFESV or without peptide, and the indicated parameters were determined. Data correspond to fivemice p
had four mice per group, and N-WT, which had three mice per group, because two mice died at 7 dpi.
representative of two experiments with B6.D2-D6 Thy1.1+ recipients (shown) and a third experiment using B
representative flow cytometry plots and for higher ECTV doses and VACV and LCMV infection.
Cell Host & Microbe 13, 546–Mice and Infections
The Fox Chase Cancer Center Institutional Animal
Care and Use Committee approved the experi-
mental protocols involving animals. C57BL/6 (B6)
mice were purchased from Taconic when they
were 8–10 weeks of age and rested at least
1 week before use in experiments. The B6.D2-
D6, IFN-g/, and B6-EGFPmicewere initially pur-
chased from Jackson Laboratory and were bred in
the Fox Chase Cancer Center Laboratory AnimalFacility. B6.D2-D6 Thy1.1 mice were generated by crossing of B6.D2-D6
with B6.PL-Thy1a/CyJmice (Jackson) and genotyped by staining of peripheral
blood mononuclear cells for Thy1.1+, NK1.1–, and Ly49H. Unless otherwise
indicated, mice were infected with ECTV in the left footpadwith 30 ml PBS con-
taining 3 3 103 plaque-forming units (pfu). VACV was inoculated via the intra-
peritoneal route with 500 ml PBS containing 106 pfu and boosted similarly
4 weeks later. After infections, mice were observed daily for signs of disease
(lethargy, ruffled hair, weight loss, skin rash, and eye secretions) and imminent
death (unresponsiveness to touch and lack of voluntary movements). When
required, mice were treated with 400 mg Cidofovir as previously (Fang and Si-
gal, 2010).
Histopathology
Histopathology was as previously described (Xu et al., 2012).
Adoptive Transfers
CD8+ cells were magnetically purified from LNs and spleens with an Automacs
magnetic cell sorter (Miltenyi Biotechnology) at the normal setting as previ-
ously described (Fang and Sigal, 2006; Xu et al., 2007). The efficiency of the
purification and percent of virus-specific cells was monitored by Kb-
TSYKFESV Dimer-X staining (BD PharMingen) and fluorescence-activated
cell sorting analysis. Unless otherwise indicated, cells were resuspended in
PBS (107/ml) and 500 ml was inoculated intravenously into recipient mice.
For experiments in Figure 4, donor cells were labeled with 4 mmCFSE (Invitro-
gen) as done previously (Xu et al., 2007). For the experiments in Figures 6 and
S5, M-IFN-g/ cells were obtained as above, and the complementing leuko-
cytes were obtained from the LNs, spleen, and livers of naive B6 mice. When
indicated, the B6 donor mice had been depleted 24 hr before transfer with
100 mg depleting CD4 (GK1.5, ATCC #HB-191), 100 mg CD8 (2.43), or
200 mg NK (PK136) monoclonal antibodies in 0.5 ml PBS intraperitoneally.
Depletion was assessed by flow cytometry. The depleting monoclonalrol of ECTV in the Liver and Spleen
+ T cells to contain 75,000 Kb-TSYKFESV+ cells.
d splenocytes (J–R) were incubated for 5 hr with
er group, with exception of uninfected mice, which
Data are represented as a mean ± SEM and are
6.D2-D6 mice as recipients. See also Figure S4 for
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Antiviral Memory CD8+ T Cells Can Outsource IFN-gantibodies were produced by the FCCC Tissue Culture Facility in CELLine bio-
reactors (BD) in Cell Animal Free Medium (BD) as directed by the manufac-
turer. Before adoptive transfer, effective depletion was confirmed by flow cy-
tometry with an aliquot of the leukocytes.
Flow Cytometry
Flow cytometry was performed as previously described (Fang and Sigal, 2006,
2010; Xu et al., 2007). The following antibodies were used: anti-CD3 (145-
2C11, Biolegend), anti-CD4 (GK1.5, Biolegend), anti-CD8a (53-6.7, Bio-
legend), anti-Thy1.1 (OX-7, Biolegend), anti-Thy1.2 (30-H12, Biolegend),
anti-IFN-g (clone XMG1.2, Biolegend), anti-CD14 (Sa14-2, Biolegend), anti-
CD16 (93, Biolegend), anti-CD19 (6D5, Biolegend), anti-CD94 (18d3, Bio-
legend), anti-CD49b (DX5, BD), anti-CD107a (1D4B, Biolegend), anti-NK1.1
(PK136, BD), anti-Ly49C/F/I/H (14B11, BD), anti-NKp46 (29A1.4,
eBioscience), and PECy5.5-labeled anti-human GzB (GzB, Caltag) that
cross-reacts with mouse GzB (Wolint et al., 2004). The hybridoma producing
monoclonal antibody 25-D1.16 was grown in Cell Line Bioreactors (BD) in an-
imal-protein-free media as recommended by the manufacturer. The 25-D1.16
monoclonal antibody in the supernatant was purified by ammonium sulfate
precipitation via standard techniques and labeled with an APEX Alexa 647
Antibody Labeling Kit (Invitrogen) as recommended by the manufacturer. For
TSYKFESV-specific TCD8+, H-2Kb:Ig recombinant fusion protein (Dimer-X,
BD) was incubated with synthetic TSYKFESV (GenScript) and used as recom-
mended by the manufacturer. Monoclonal antibody 25.D-1-stained cells were
analyzed by flow cytometry at the Fox Chase Cell Sorting Facility with a LSR II
system (BD). At least 100,000 cells were analyzed.
Data Display and Statistical Analysis
Unless otherwise indicated, all displayed data correspond to one representa-
tive experiment of at least two similar experiments with groups of three to six
mice. Statistical analysis was performed with Graph Pad Prism software. For
survival studies, p values were obtained with the log-rank (Mantel-Cox) test.
All other statistical analyses were performed with an unpaired two-tailed
t test or the Mann-Whitney test as applicable. When applicable, data is dis-
played with mean ± SEM. p values were determined betweenM-WT recipients
and all other groups. *p < 0.05, **p < 0.01, and ***p < 0.001. When not marked,
the differences were not statistically significant. Unless specifically indicated,
all groups were compared to M-WT recipients.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
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